Varivax vaccine with diluents
Ended Awarded
- Contract number
- SPE2DB25FU9PX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,530
Award facts
- Contract value 100% obligated
- $10,530.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,530.10 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. This order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery against the contractor's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract carries no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across the Department of Defense and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's comprehensive DLA IDC (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which establishes the company as a global pharmaceutical prime vendor supporting military healthcare programs worldwide. The Varivax vaccine delivery fulfills DLA's ongoing medical supply requirements and represents typical ordering activity under this expansive contract vehicle, which encompasses a broad range of pharmaceutical products, vaccines, and medical supplies. The contractor's proven capability in managing large-scale federal vaccine and pharmaceutical distribution makes it well-positioned to support DLA's global medical logistics mission.
Quick answers
Who was awarded contract SPE2DB25FU9PX?
SPE2DB25FU9PX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FU9PX worth?
The government has obligated $10,530 on SPE2DB25FU9PX.
Is contract SPE2DB25FU9PX an order under another contract?
Yes. SPE2DB25FU9PX is a delivery order under SPE2DB22D1052, an indefinite delivery contract.
Was contract SPE2DB25FU9PX competed?
The extent of competition for SPE2DB25FU9PX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award